Lower Ventral Striatum Activity Associated With Depression in Teens
Researchers used data from a European sample of teens from the IMAGEN Consortium study, which measured resting-state fMRI activity at age 14, 16, and 18.
Researchers used data from a European sample of teens from the IMAGEN Consortium study, which measured resting-state fMRI activity at age 14, 16, and 18.
Investigators at King’s College London in the UK evaluated data from a national database of adolescents aged who were enrolled in 4 state-maintained school and resident programs from their 11th birthday or April 2009 to presentation at an emergency department for self-harm, their 18th birthday, or March 2013.
Researchers investigated the mortality risk associated with depression in patients with incident rheumatoid arthritis.
In a quantitative study, researchers assessed the efficacy of TMS on depressive symptoms in people with MS.
Zuranolone is an investigational oral neuroactive steroid GABA-A receptor positive allosteric modulator.
Compared with its use for chronic pain, reliable evidence to support the use of cannabis to treat anxiety is lacking and available data are “conflicting.” To bring clarity to the issue, researchers conducted a retrospective database study of Canadian medical cannabis patients.
Rates of anxiety and depression have increased during the pandemic and are linked to preeclampsia risk, making screening for mental health conditions at prenatal visits essential.
The ENGAGE-2 Mechanistic Pilot trial was a randomized clinical trial conducted at the University of Illinois at Chicago and Stanford University between 2019 and 2020.
This study was a cross-sectional analysis of data from the Youth Aware of Mental Health promotion program which took place in Texas.
The researchers evaluated socioeconomic data from the 2011 Combining Medications to Enhance Depression Outcomes (CO-MED) study to ascertain whether social determinants affect treatment response in those with major depression.